CLINICAL TRIALS PROFILE FOR HIPREX
✉ Email this page to a colleague
All Clinical Trials for HIPREX
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02358993 ↗ | Short-course Methenamine Hippurate for Prevention of Post-operative UTI | Completed | University of Pennsylvania | N/A | 2014-12-01 | The investigators will determine the efficacy of an innovative short regimen of methenamine hippurate on prevention of post-operative UTI in patients requiring short-term catheterization after pelvic reconstructive surgery through a single-blind, randomized controlled trial. Primary outcome will be the rate of symptomatic UTI within 3 weeks of catheter removal. The investigators will study cost-effectiveness, antibiotic resistance profiles, and adverse drug effects. Findings may reduce antibiotic use and nosocomial UTIs. |
| NCT04709601 ↗ | Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections. | Recruiting | University of Texas Southwestern Medical Center | Phase 4 | 2021-01-04 | The purpose of this study is to measure the concentration of formaldehyde in the urine of women with recurrent urinary tract infections on Hiprex; and then, assuming its urinary presence is confirmed at the proper acid urinary pH, evaluate if such a therapy has favorable effects in decreasing the rate of recurrent urinary tract infections over time. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for HIPREX
Condition Name
Clinical Trial Locations for HIPREX
Trials by Country
Clinical Trial Progress for HIPREX
Clinical Trial Phase
Clinical Trial Sponsors for HIPREX
Sponsor Name
